A Special One-Time Only Invitation for Stansberry Research Subscribers Only

This is our most important work by far.

I believe it’ll make our subscribers a fortune over the next 48 months.

That’s because the coming default in U.S. corporate debt – what we call The Greatest Legal Transfer of Wealth in History – will open the doors to once-in-a-decade investment opportunity.

The last time the setup was this ideal was in the aftermath of the 2008 financial crisis.

While the global economy crashed and investors suffered catastrophic losses, my team and I went on a shopping spree.

We recommended 50 different distressed investments, 40 of which were profitable. That’s an 80% win rate.

And these were huge winners. I’m talking about double-digit yields and capital gains. In fact, our average return – including winners and losers – was a staggering 38%.

However, during this new debt default crisis, I believe the returns could potentially be even larger.

Not only because the coming collapse in corporate debt could be greater than any we have ever seen before but because this time I’ve teamed up with “the Dean of high yield debt”…

Wall Street legend Marty Fridson will show you how to safely invest in distressed bonds and equities for double-digit annual yields, along with double-digit gains on top.

Every second Friday, Marty will send you a new report detailing either the current state of the bond markets or exploring one new distressed opportunity.

You’ll also get instant access to our backlog of issues, model portfolio, guide to buying distressed investments, and much, much more.

Renowned Wall Street analyst Tom Carroll will show you how to profit from one of the financial market’s most powerful yet overlooked forces – activist investors.

Tom will take you inside the proxy battles, the takeover fights, and the corporate restructurings that can unleash billions in value almost overnight.

Tom knows many of the activists on a first-name basis. Through his personal contacts, in-depth financial and business analysis, and decades of experience, he will find the most lucrative investment opportunities for you.

In simple terms, Tom is looking for companies with the potential to be exceptional but that have been driven into the ground.

We’re talking about companies with flat or falling revenues, shrinking market share, weak operations, an atrocious CEO or board of directors… the list of ways you can abuse a great business is endless.

But when the activists get involved in these firms, the upside potential is massive because they will force the changes needed to unlock the value and drive shareholder returns.

Right now, we have several unique investment opportunities:

Grossly undervalued companies that Wall Street has written off due to poor performance but that activists are positioning to engineer a turnaround that could send the company soaring to new highs.

Inside Porter & Co. Activist Investor, you’ll get all of Tom’s research, all his recommendations, the model portfolio, ongoing analysis, buy and sell alerts, and much, much more.

The Investment Chronicles is like your own in-house research team.

We extract the most valuable and lucrative data from hundreds of sources and condense it all into one simple monthly report.

Our team analyzes hedge fund letters, annual reports, SEC filings, investment newsletters, newspapers, Twitter threads, conferences, podcasts, and countless other sources…

Then, we boil the key insights, investment ideas, and trends into one carefully curated report that gives the discerning investor everything they need to navigate the markets better.

Our goal with this Legacy Clause is to help you leave a legacy for your family. So even after you’re finished with our work, the next generation of your family can benefit from our research.

Simply let my team know to whom you’d like to gift your Partner Pass membership, and we will ensure they have ongoing access to all of our work.

Our Partners also receive every new advisory we launch in the future.

Everything – every new service, briefing, recommendation, analyst – is yours. At no extra cost. Simply join as a Partner, and you’ll lock it all in – forever.

Right now, the investment to become a Partner is $8,500.

But with the release of our new biotech advisory in January, the cost to become a Partner Pass member will increase to $10,000… and will continue to increase with every new service we add.

While I’m aware that’s a significant amount, it’s a small fraction of the value you get (especially considering the annual value of your Partner Pass benefits is well over $15,000).

And remember, this investment is for everything we produce now and in the future - all you’ll ever pay is a small annual maintenance fee of $299.